The global hematology instruments and reagents market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by factors such as increasing prevalence of chronic diseases, rising demand for personalized medicine, and technological advancements in hematology instruments and reagents.
Hematology Instruments: Hematology instruments are used for the diagnosis of various blood disorders such as anemia, leukemia, lymphoma, sickle cell disease etc, which are majorly used in hospitals and clinical testing labs. The demand for these products is expected to increase due to the rise in prevalence of chronic diseases such as cancer and diabetes mellitus type 2 among others. Furthermore, technological advancements in hematology instruments have led to their increased usage across various applications including research institutes where they are used for research purposes or clinical testing labs where they are used for diagnostic purposes.
Hematology Reagents: Hematology reagents include chemicals that react with blood cells or other substances found in blood samples during a laboratory test procedure; these chemicals can be either purchased separately or pre-packaged with other laboratory equipment (e.g., centrifuge). These products are mainly used by commercial organizations such as hospitals or laboratories that offer diagnostic services on a fee-for-service basis; however there has been an increase in their use among research institutes due to their ability to provide accurate results without any interference from external factors like temperature fluctuations etc, which may affect the accuracy of results obtained from other methods like manual counting techniques etc, thereby leading them towards adopting automated methods like flow cytometry technique which requires hematological reagents among others.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is driving the growth of the global Hematology Instruments and Reagents market.
- Increasing demand for point-of-care diagnostic tests in emerging economies such as India and China is also driving the growth of the global Hematology Instruments and Reagents market.
- The increasing number of mergers & acquisitions in this industry is also driving the growth of this market.
- The increasing adoption rate for hematological instruments by hospitals due to their accuracy in diagnosis.
Industry Growth Insights published a new data on “Hematology Instruments and Reagents Market”. The research report is titled “Hematology Instruments and Reagents Market research by Types (Hematology Instruments, Hematology Reagents), By Applications (Stand-Alone Hospitals, Commercial Organizations, Clinical Testing Labs, Research Institutes), By Players/Companies Sysmex, Danaher, Nihon Kohden, Siemens, Abbott Laboratories, Boule Diagnostics, HORIBA, Diatron, Drew Scientific, EKF Diagnostics, Mindray, Roche”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hematology Instruments and Reagents Market Research Report
By Type
Hematology Instruments, Hematology Reagents
By Application
Stand-Alone Hospitals, Commercial Organizations, Clinical Testing Labs, Research Institutes
By Companies
Sysmex, Danaher, Nihon Kohden, Siemens, Abbott Laboratories, Boule Diagnostics, HORIBA, Diatron, Drew Scientific, EKF Diagnostics, Mindray, Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Hematology Instruments and Reagents Market Report Segments:
The global Hematology Instruments and Reagents market is segmented on the basis of:
Types
Hematology Instruments, Hematology Reagents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Stand-Alone Hospitals, Commercial Organizations, Clinical Testing Labs, Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sysmex
- Danaher
- Nihon Kohden
- Siemens
- Abbott Laboratories
- Boule Diagnostics
- HORIBA
- Diatron
- Drew Scientific
- EKF Diagnostics
- Mindray
- Roche
Highlights of The Hematology Instruments and Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hematology Instruments
- Hematology Reagents
- By Application:
- Stand-Alone Hospitals
- Commercial Organizations
- Clinical Testing Labs
- Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hematology Instruments and Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hematology instruments and reagents are used to measure the amount of blood in a sample.
Some of the key players operating in the hematology instruments and reagents market are Sysmex, Danaher, Nihon Kohden, Siemens, Abbott Laboratories, Boule Diagnostics, HORIBA, Diatron, Drew Scientific, EKF Diagnostics, Mindray, Roche.
The hematology instruments and reagents market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hematology Instruments and Reagents Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hematology Instruments and Reagents Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hematology Instruments and Reagents Market - Supply Chain
4.5. Global Hematology Instruments and Reagents Market Forecast
4.5.1. Hematology Instruments and Reagents Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hematology Instruments and Reagents Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hematology Instruments and Reagents Market Absolute $ Opportunity
5. Global Hematology Instruments and Reagents Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hematology Instruments and Reagents Market Size and Volume Forecast by Type
5.3.1. Hematology Instruments
5.3.2. Hematology Reagents
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hematology Instruments and Reagents Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hematology Instruments and Reagents Market Size and Volume Forecast by Application
6.3.1. Stand-Alone Hospitals
6.3.2. Commercial Organizations
6.3.3. Clinical Testing Labs
6.3.4. Research Institutes
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hematology Instruments and Reagents Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hematology Instruments and Reagents Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hematology Instruments and Reagents Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hematology Instruments and Reagents Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hematology Instruments and Reagents Demand Share Forecast, 2019-2026
9. North America Hematology Instruments and Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hematology Instruments and Reagents Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hematology Instruments and Reagents Market Size and Volume Forecast by Application
9.4.1. Stand-Alone Hospitals
9.4.2. Commercial Organizations
9.4.3. Clinical Testing Labs
9.4.4. Research Institutes
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hematology Instruments and Reagents Market Size and Volume Forecast by Type
9.7.1. Hematology Instruments
9.7.2. Hematology Reagents
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hematology Instruments and Reagents Demand Share Forecast, 2019-2026
10. Latin America Hematology Instruments and Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hematology Instruments and Reagents Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hematology Instruments and Reagents Market Size and Volume Forecast by Application
10.4.1. Stand-Alone Hospitals
10.4.2. Commercial Organizations
10.4.3. Clinical Testing Labs
10.4.4. Research Institutes
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hematology Instruments and Reagents Market Size and Volume Forecast by Type
10.7.1. Hematology Instruments
10.7.2. Hematology Reagents
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hematology Instruments and Reagents Demand Share Forecast, 2019-2026
11. Europe Hematology Instruments and Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hematology Instruments and Reagents Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hematology Instruments and Reagents Market Size and Volume Forecast by Application
11.4.1. Stand-Alone Hospitals
11.4.2. Commercial Organizations
11.4.3. Clinical Testing Labs
11.4.4. Research Institutes
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hematology Instruments and Reagents Market Sze and Volume Forecast by Type
11.7.1. Hematology Instruments
11.7.2. Hematology Reagents
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hematology Instruments and Reagents Demand Share, 2019-2026
12. Asia Pacific Hematology Instruments and Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hematology Instruments and Reagents Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hematology Instruments and Reagents Market Size and Volume Forecast by Application
12.4.1. Stand-Alone Hospitals
12.4.2. Commercial Organizations
12.4.3. Clinical Testing Labs
12.4.4. Research Institutes
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hematology Instruments and Reagents Market Size and Volume Forecast by Type
12.7.1. Hematology Instruments
12.7.2. Hematology Reagents
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hematology Instruments and Reagents Demand Share, 2019-2026
13. Middle East & Africa Hematology Instruments and Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hematology Instruments and Reagents Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hematology Instruments and Reagents Market Size and Volume Forecast by Application
13.4.1. Stand-Alone Hospitals
13.4.2. Commercial Organizations
13.4.3. Clinical Testing Labs
13.4.4. Research Institutes
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hematology Instruments and Reagents Market Size and Volume Forecast by Type
13.7.1. Hematology Instruments
13.7.2. Hematology Reagents
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hematology Instruments and Reagents Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hematology Instruments and Reagents Market: Market Share Analysis
14.2. Hematology Instruments and Reagents Distributors and Customers
14.3. Hematology Instruments and Reagents Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sysmex
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Danaher
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nihon Kohden
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Siemens
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbott Laboratories
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Boule Diagnostics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. HORIBA
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Diatron
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Drew Scientific
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. EKF Diagnostics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Mindray
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Roche
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
